Elanco Animal Health Inc ELAN Income Statement

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17
Revenue
2,997	3,071	3,083	3,073	3,061	3,066	3,021	2,957	2,920	2,889	0	0	0
Costs, expenses and other:
Cost of sales
1,459	1,470	1,472	1,482	1,557	1,573	1,566	1,572	1,515	1,493	0	0	0
Research and development
272	270	263	252	245	246	247	0	0	-	0	-	-
Marketing, selling and administrative
761	760	759	746	736	735	744	0	0	-	0	-	-
Amortization of intangible assets
203	200	199	197	197	197	198	0	0	-	0	-	-
Asset impairment, restructuring and other special charges (Note 7)
235	185	179	115	151	128	268	279	270	375	0	0	0
Interest expense, net of capitalized interest
74	78	81	71	50	29	8	0	0	0	-	0	0
Other–net, expense
-25	-27	-46	-37	-42	-41	-13	0	0	-	0	-	-
Costs, expenses and other
3,032	2,992	3,003	2,901	2,980	2,952	2,857	0	0	-	0	-	-
Income (loss) before income taxes
-34	78	80	171	81	114	-39	-127	-102	-232	0	0	0
Income tax (benefit) expense
-21	10	-13	27	36	27	52	45	37	78	0	0	0
Net income (loss)
-12	67	93	144	45	86	-91	-172	-139	-310	0	0	0
Earnings (loss) per share:
Basic (usd per share)
-0.12	-0.04	0.03	0.10	0.09	0.04	0.20	-0.21	0.25	-	-	-	-
Diluted (usd per share)
-0.12	-0.04	0.03	0.10	0.09	0.04	0.20	-0.21	0.25	-	-	-	-
Earnings Per Share, Basic and Diluted
-	-	-	-	-	0.04	-	-	-	-0.55	-0.06	-0.10	-0.34
Weighted average shares outstanding:
Basic (in shares)
403	373	371	365	365	367	301	293	293	-	-	-	-
Diluted (in shares)
403	375	373	367	366	367	301	293	293	-	-	-	-
Basic and diluted (in shares)
-	-	-	-	-	-	-	-	-	-	365	-	-